Diagnostic delays and sexual health integration in <i>Chlamydia trachomatis</i> conjunctivitis: an 11-year retrospective study at a UK tertiary ophthalmic centre. [PDF]
Milligan AL +8 more
europepmc +1 more source
Tocilizumab for severe and refractory mucous membrane pemphigoid
Elevated IL‐6 levels identified in mucous membrane pemphigoid support IL‐6 blockade, with tocilizumab demonstrating clinical benefit in nine patients with severe and refractory mucous membrane pemphigoid. Abstract Background Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease involving mucous membranes with a potentially ...
Billal Tedbirt +20 more
wiley +1 more source
Sustained Tear Film Exposure After Parenteral Cefovecin Administration in Dogs: Pharmacokinetics and Relevance to Canine Bacterial Keratitis. [PDF]
McClure MR +5 more
europepmc +1 more source
Lessons for Immunisation Policy and Practice From the Deadly Measles Resurgence in Bangladesh
ABSTRACT Bangladesh is experiencing one of the deadliest outbreaks of measles in 2026, with at least 472 suspected child deaths and over 67,079 suspected cases as of 27 May 2026. It has happened primarily following a fall in measles vaccination coverage in 2025, largely due to the cancellation of a planned 2024 Measles–Rubella vaccination Campaign and ...
Md Masudul Haque +6 more
wiley +1 more source
Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus. [PDF]
González-Mancebo E +11 more
europepmc +1 more source
Isolated Allergic Conjunctivitis Induced by an Oral Nonsteroidal Anti-inflammatory Drug (NSAID), Confirmed by an Oral Provocation Test: A Case Report. [PDF]
Hidan Y, Chafi J.
europepmc +1 more source
Diagnosis of chlamydial and gonococcal conjunctivitis: performance evaluation of a nucleic acid amplification test. [PDF]
Bédard O +10 more
europepmc +1 more source
GWAS of Second‐Generation Antihistamine Use: Locus Specificity and Highlighted Signalling Pathways
Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1224-1226, October 2026.
M. Niemi +15 more
wiley +1 more source
Microneedle-based drug delivery for inflammatory and immune-mediated ocular diseases: current applications and future perspectives. [PDF]
Mi B, Jin F, Mu J, Hua X.
europepmc +1 more source

